Which lesions can be treated with blue laser in aesthetics?

The 450 nm blue laser can treat superficial benign lesions such as skin tags, cherry angiomas, telangiectasias, sebaceous hyperplasia, or milia, always subject to prior dermatological validation.

Other skin lesions, although benign, require diagnosis and treatment in a medical setting.

An aesthetic device with a clinical foundation and European regulatory compliance

Milesman Blauman is a device for aesthetic use that complies with current European regulations, including the regulatory framework updated in recent years regarding safety and medical devices.

This means that:

• it has been developed under safety and control criteria
• it meets the technical standards required in the European Union
• it is designed for professional use in an aesthetic setting

And, at the same time, its technical capability means it can also be used in a medical setting for the treatment of specific skin lesions, under clinical judgment.

This is where it is worth making something clear from the outset: the equipment is the same. The responsibility is not.

What an aesthetics professional can treat (and under what conditions)

The Blauman blue laser allows for the treatment of benign lesions in aesthetics when dealing with superficial lesions and always under one essential condition: prior validation.

In the Milesman way of working, this validation is carried out through a dermatological platform, which makes it possible to confirm the nature of the lesion before treatment.

This step is not optional; it is a mandatory part of the process.

Lesions that can be addressed in aesthetics with blue laser

Once the benign nature of the lesion and its suitability for blue laser treatment have been confirmed, there are indications that can be treated safely in the treatment room:

• skin tags
• cherry angiomas
• fine telangiectasias
• sebaceous hyperplasia
• Milia
• fibrous papules
• seborrheic keratoses
• benign lentigines
• certain nevi, exclusively after medical assessment

These are lesions that share common characteristics:

• superficial location (epidermis or papillary dermis)
• clear clinical demarcation
• known benign behavior
• no involvement of deep structures

In this context, the laser allows for a precise and controlled approach in the treatment of benign skin lesions.

And that, in daily clinical practice, translates into problem-solving capability with control over the procedure.

Which lesions require medical management

There are benign lesions that require medical management, not because of the technology itself, but because of what they involve at a clinical level:

• xanthelasma
• syringomas
• angiomas of greater complexity or extent
• molluscum contagiosum
• certain warts (depending on location, extent, or progression)
• mucosal lesions
• nail pathology (such as onychomycosis or other disorders)
• rosacea and associated vascular disorders
• extensive vascular lesions, which require a comprehensive approach
• cysts, lipomas, and other subcutaneous lesions
• dermatofibromas

In these cases, factors come into play that go beyond the aesthetic field:

• the need for differential diagnosis
• assessment of clinical progression
• the actual depth of the lesion
• anatomical location
• a possible pathological component

And this completely changes the approach to laser treatment in aesthetic medicine.

It is not the technology that limits the treatment; it is clinical judgment that defines it.

Areas where there is no doubt

Beyond the type of lesion, there are locations where the approach must always be medical:

• eyelids and the periocular area
• mucous membranes
• intimate areas

Even in seemingly simple lesions, anatomical complexity determines the treatment.

The real role of prior validation in laser treatments

Working with a 450 nm blue laser on skin lesions entails a clear responsibility: knowing precisely what is being treated.

That is why prior validation is not a recommendation; it is the foundation of the procedure.

It makes it possible to:

• confirm the nature of the lesion
• reduce the risk of diagnostic error
• define the appropriate treatment setting
• work with greater safety and predictability

And, in addition, it positions the clinic at a higher professional level.

What the Blauman blue laser truly brings to the treatment of benign lesions

The value of this technology lies in working with precision within the correct indications.

It makes it possible to:

• address selected benign lesions in a controlled way
• optimize treatment times
• standardize procedures

And, above all, it makes it possible to integrate the treatment within a clear framework:

• what to treat
• what not to treat
• when to treat
• and when to refer

The difference is not set by the equipment

In advanced aesthetics, growth does not come from doing more; it comes from doing better.

From recognizing a treatable lesion.

From identifying a lesion that is not.

And from understanding when the treatment does not belong to the aesthetic field.

The 450 nm blue laser makes it possible to work with a high level of precision in the treatment of benign lesions.

But that precision only has value when it is backed by something more important: professional judgment.

Do you want to bring the Milesman Blauman blue laser into your clinic?

If you want to bring in the Milesman Blauman blue laser, you can get in touch with our team to receive personalized guidance.

We help you integrate this technology into your professional practice, both in advanced aesthetics and in aesthetic medicine, with training and dermatological validation included.